Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 866 JPY 2.93%
Market Cap: 676.9B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

282.1B
+1%
Revenue
Growth Rates:
1 Year
+10%
3 Years
+49%
5 Years
+51%
7 Years
+74%
10 Years
+93%
36.9B
-9%
Operating Income
Growth Rates:
1 Year
-5%
3 Years
+39%
5 Years
+80%
7 Years
+109%
10 Years
+153%
27.3B
-10%
Net Income
Growth Rates:
1 Year
-8%
3 Years
+24%
5 Years
+179%
7 Years
+138%
10 Years
+241%

Earnings Waterfall
Rohto Pharmaceutical Co Ltd

Revenue
282.1B JPY
Cost of Revenue
-120.2B JPY
Gross Profit
161.8B JPY
Operating Expenses
-125B JPY
Operating Income
36.9B JPY
Other Expenses
-9.6B JPY
Net Income
27.3B JPY

Income Statement
Rohto Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
146 495
N/A
148 167
+1%
151 774
+2%
157 167
+4%
161 852
+3%
164 639
+2%
167 016
+1%
164 467
-2%
160 973
-2%
158 115
-2%
154 599
-2%
157 557
+2%
161 799
+3%
167 286
+3%
171 742
+3%
176 543
+3%
180 503
+2%
182 328
+1%
183 582
+1%
184 854
+1%
186 751
+1%
187 006
+0%
188 327
+1%
185 058
-2%
180 903
-2%
179 819
-1%
181 287
+1%
184 961
+2%
189 302
+2%
195 698
+3%
199 646
+2%
209 586
+5%
218 940
+4%
231 887
+6%
238 664
+3%
247 580
+4%
256 220
+3%
263 564
+3%
270 840
+3%
278 025
+3%
282 053
+1%
Gross Profit
Cost of Revenue
(59 356)
(60 386)
(61 395)
(63 583)
(65 059)
(65 957)
(67 250)
(66 502)
(65 234)
(64 589)
(63 254)
(64 596)
(66 669)
(68 661)
(70 746)
(71 790)
(72 827)
(73 754)
(74 048)
(74 870)
(75 577)
(74 728)
(74 135)
(73 296)
(71 970)
(72 471)
(74 326)
(75 802)
(78 289)
(81 106)
(83 476)
(87 891)
(92 643)
(97 957)
(101 243)
(103 983)
(107 319)
(110 158)
(113 554)
(117 435)
(120 219)
Gross Profit
87 139
N/A
87 781
+1%
90 379
+3%
93 584
+4%
96 793
+3%
98 682
+2%
99 766
+1%
97 965
-2%
95 739
-2%
93 526
-2%
91 345
-2%
92 961
+2%
95 130
+2%
98 625
+4%
100 996
+2%
104 753
+4%
107 676
+3%
108 574
+1%
109 534
+1%
109 984
+0%
111 174
+1%
112 278
+1%
114 192
+2%
111 762
-2%
108 933
-3%
107 348
-1%
106 961
0%
109 159
+2%
111 013
+2%
114 592
+3%
116 170
+1%
121 695
+5%
126 297
+4%
133 930
+6%
137 421
+3%
143 597
+4%
148 901
+4%
153 406
+3%
157 286
+3%
160 590
+2%
161 834
+1%
Operating Income
Operating Expenses
(72 536)
(75 093)
(77 220)
(79 265)
(81 657)
(82 665)
(84 083)
(81 922)
(80 764)
(77 310)
(75 894)
(76 294)
(77 489)
(79 959)
(81 909)
(84 038)
(86 534)
(87 902)
(88 722)
(90 373)
(90 679)
(90 532)
(91 636)
(89 491)
(86 597)
(86 466)
(83 971)
(83 718)
(84 444)
(84 709)
(87 155)
(91 117)
(94 634)
(99 531)
(103 462)
(107 942)
(110 245)
(112 783)
(117 238)
(120 044)
(124 961)
Selling, General & Administrative
(72 474)
(75 042)
(70 551)
(79 206)
(81 598)
(82 635)
(76 241)
(81 442)
(80 304)
(76 840)
(68 414)
(76 262)
(77 408)
(79 919)
(74 106)
(84 033)
(86 608)
(88 045)
(80 602)
(90 402)
(90 758)
(90 531)
(82 529)
(89 202)
(86 216)
(86 144)
(74 023)
(83 350)
(84 158)
(84 413)
(76 301)
(90 270)
(94 633)
(99 531)
(90 057)
(106 648)
(110 243)
(112 780)
(101 424)
(120 043)
(124 960)
Research & Development
0
0
(5 585)
0
0
0
0
0
0
0
(6 123)
0
0
0
(6 553)
0
0
0
(6 831)
0
0
0
(7 050)
0
0
0
(7 903)
0
0
0
(8 740)
0
0
0
(11 065)
0
0
0
(13 390)
0
0
Depreciation & Amortization
0
0
(1 304)
0
0
0
(1 491)
0
0
0
(1 356)
0
0
0
(1 303)
0
0
0
(1 379)
0
0
0
(2 104)
0
0
0
(1 810)
0
0
0
(2 113)
0
0
0
(2 339)
0
0
0
(2 423)
0
0
Other Operating Expenses
(62)
(51)
220
(59)
(59)
(30)
(6 351)
(480)
(460)
(470)
(1)
(32)
(81)
(40)
53
(5)
74
143
90
29
79
(1)
47
(289)
(381)
(322)
(235)
(368)
(286)
(296)
(1)
(847)
(1)
0
(1)
(1 294)
0
(3)
(1)
(1)
(1)
Operating Income
14 603
N/A
12 688
-13%
13 159
+4%
14 319
+9%
15 136
+6%
16 017
+6%
15 683
-2%
16 043
+2%
14 975
-7%
16 216
+8%
15 451
-5%
16 667
+8%
17 641
+6%
18 666
+6%
19 087
+2%
20 715
+9%
21 142
+2%
20 672
-2%
20 812
+1%
19 611
-6%
20 495
+5%
21 746
+6%
22 556
+4%
22 271
-1%
22 336
+0%
20 882
-7%
22 990
+10%
25 441
+11%
26 569
+4%
29 883
+12%
29 015
-3%
30 578
+5%
31 663
+4%
34 399
+9%
33 959
-1%
35 655
+5%
38 656
+8%
40 623
+5%
40 048
-1%
40 546
+1%
36 873
-9%
Pre-Tax Income
Interest Income Expense
854
1 042
984
1 030
593
409
(155)
(302)
(332)
66
1 639
1 524
1 380
1 046
(338)
(157)
64
94
(1 801)
(2 041)
(1 877)
(1 171)
1 859
1 832
1 810
1 060
1 812
2 139
1 991
2 327
722
1 098
1 574
1 007
2 109
2 132
2 289
2 464
1 764
2 173
2 330
Non-Reccuring Items
(3 204)
(3 061)
(862)
(756)
(491)
(606)
(1 107)
(1 502)
(1 436)
(1 536)
(2 541)
(2 188)
(2 313)
(2 111)
(2 028)
(2 147)
(2 070)
(2 546)
(2 669)
(3 362)
(2 715)
(2 301)
(2 601)
(2 819)
(4 067)
(5 050)
(3 640)
(2 639)
(1 115)
(516)
(952)
0
(1 609)
(968)
(1 294)
0
(1 275)
(1 942)
(916)
(1 134)
(1 583)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153
153
153
153
0
(16)
0
2 707
0
0
0
0
0
0
0
0
0
0
0
0
39
39
Total Other Income
117
169
470
251
340
322
(118)
(50)
(12)
21
203
268
205
147
99
(16)
(31)
(49)
(42)
32
153
272
(237)
(48)
(367)
2 290
(863)
1 805
1 192
(1 500)
(911)
(444)
113
(507)
(484)
(910)
(646)
188
622
(254)
(109)
Pre-Tax Income
12 370
N/A
10 838
-12%
13 751
+27%
14 844
+8%
15 578
+5%
16 142
+4%
14 303
-11%
14 189
-1%
13 195
-7%
14 767
+12%
14 752
0%
16 271
+10%
16 913
+4%
17 748
+5%
16 820
-5%
18 395
+9%
19 105
+4%
18 171
-5%
16 300
-10%
14 393
-12%
16 209
+13%
18 699
+15%
21 730
+16%
21 236
-2%
19 696
-7%
19 182
-3%
23 006
+20%
26 746
+16%
28 637
+7%
30 194
+5%
27 874
-8%
31 232
+12%
31 741
+2%
33 931
+7%
34 290
+1%
36 877
+8%
39 024
+6%
41 333
+6%
41 518
+0%
41 370
0%
37 550
-9%
Net Income
Tax Provision
(4 356)
(4 216)
(5 123)
(5 544)
(5 666)
(5 566)
(5 217)
(5 058)
(4 794)
(5 061)
(4 738)
(5 345)
(5 432)
(6 049)
(7 483)
(7 888)
(8 083)
(8 026)
(6 481)
(5 800)
(6 397)
(7 182)
(6 448)
(6 422)
(5 937)
(5 788)
(6 236)
(6 964)
(6 620)
(6 917)
(6 686)
(7 654)
(8 230)
(8 044)
(7 860)
(8 261)
(9 053)
(10 207)
(10 123)
(10 742)
(10 170)
Income from Continuing Operations
8 014
6 622
8 628
9 300
9 912
10 576
9 086
9 131
8 401
9 706
10 014
10 926
11 481
11 699
9 337
10 507
11 022
10 145
9 819
8 593
9 812
11 517
15 282
14 814
13 759
13 394
16 770
19 782
22 017
23 277
21 188
23 578
23 511
25 887
26 430
28 616
29 971
31 126
31 395
30 628
27 380
Income to Minority Interest
(13)
(13)
3
9
14
14
12
12
14
0
(2)
(11)
(10)
1
(47)
(53)
(63)
(85)
(18)
(14)
(24)
(27)
127
124
144
161
(27)
(37)
(50)
(131)
(60)
(136)
(145)
(164)
(52)
(142)
(190)
(227)
(457)
(297)
(117)
Net Income (Common)
8 002
N/A
6 608
-17%
8 631
+31%
9 311
+8%
9 926
+7%
10 591
+7%
9 098
-14%
9 143
+0%
8 416
-8%
9 705
+15%
10 011
+3%
10 913
+9%
11 467
+5%
11 699
+2%
9 289
-21%
10 454
+13%
10 959
+5%
10 058
-8%
9 799
-3%
8 576
-12%
9 787
+14%
11 490
+17%
15 410
+34%
14 940
-3%
13 902
-7%
13 555
-2%
16 743
+24%
19 745
+18%
21 968
+11%
23 146
+5%
21 127
-9%
23 440
+11%
23 365
0%
25 722
+10%
26 377
+3%
28 473
+8%
29 779
+5%
30 897
+4%
30 936
+0%
30 328
-2%
27 263
-10%
EPS (Diluted)
70.19
N/A
57.96
-17%
75.73
+31%
81.67
+8%
87.07
+7%
92.9
+7%
79.69
-14%
80.2
+1%
73.82
-8%
85.13
+15%
43.78
-49%
95.72
+119%
100.58
+5%
102.62
+2%
40.6
-60%
91.7
+126%
96.13
+5%
87.92
-9%
42.83
-51%
74.96
+75%
85.56
+14%
100.44
+17%
67.36
-33%
130.6
+94%
121.52
-7%
118.49
-2%
73.18
-38%
172.6
+136%
96.29
-44%
101.15
+5%
92.34
-9%
102.44
+11%
102.12
0%
112.42
+10%
115.29
+3%
124.44
+8%
130.16
+5%
135.02
+4%
135.21
+0%
132.58
-2%
119.5
-10%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.